Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Uterine Cervical Neoplasms × Everolimus × Clear all

Phase

Status

Withdrawn 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 52 Carcinoma, Renal Cell 47 Neoplasm Metastasis 24 Neoplasms 18 Kidney Neoplasms 18 Neuroendocrine Tumors 17 Carcinoma, Non-Small-Cell Lung 13 Tuberous Sclerosis 12 Stomach Neoplasms 12 Lymphoma, Mantle-Cell 12 Lymphoma, Large B-Cell, Diffuse 11 Recurrence 10 Prostatic Neoplasms 10 Lymphoma 10 Hodgkin Disease 10 Glioblastoma 10 Colorectal Neoplasms 10 Precursor Cell Lymphoblastic Leukemia-Lymphoma 9 Brain Neoplasms 9 Lymphoma, Follicular 8 Lung Neoplasms 8 Leukemia, Lymphocytic, Chronic, B-Cell 8 Carcinoma 8 Waldenstrom Macroglobulinemia 7 Triple Negative Breast Neoplasms 7 Sarcoma 7 Multiple Myeloma 7 Lymphoma, B-Cell, Marginal Zone 7 Glioma 7 Central Nervous System Neoplasms 7

Interventions

Cisplatin 71 Brachytherapy 31 Radiotherapy 26 Paclitaxel 22 Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 21 human papillomavirus vaccine, L1 type 16, 18 20 Topotecan 18 Surveys and Questionnaires 17 Papillomavirus Vaccines 17 Carboplatin 17 Bevacizumab 15 pembrolizumab 14 Radiation 12 Gemcitabine 12 Early Intervention, Educational 12 Colposcopy 12 Methods 11 Magnetic Resonance Spectroscopy 11 Radiotherapy, Intensity-Modulated 10 Blood Specimen Collection 10 atezolizumab 9 Papanicolaou Test 9 Docetaxel 9 Vaccines, Synthetic 8 Platinum 8 Nivolumab 8 Ipilimumab 8 Counseling 8 1,2-diaminocyclohexaneplatinum II citrate 8 Vaccines 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01217177 2015-04-03

PHOENIX I

Novartis

Phase 1 Completed

Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡